Reigetsu Yoshikawa
- Oncology top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Pathology and Forensic Medicine top 10%
- Rheumatology top 10%
- Co-authors
- Hidenori YanagiTomoko Hashimoto-TamaokiMasafumi NodaYoshinori FujiwaraTomohiko YamamuraM. KusunokiJun-ichi FuruyamaTakehira Yamamura
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (8 papers)Gastric Cancer Management and Outcomes (8 papers)Colorectal Cancer Treatments and Studies (7 papers)
- Cited by
- OncologyRheumatologyHepatology
- Partner nations
- JapanUnited StatesTaiwan
In The Last Decade
Reigetsu Yoshikawa
36 papers receiving 692 citations
Peers
Comparison fields: 5 of 77
- Oncology 292
- Molecular Biology 243
- Pulmonary and Respiratory Medicine 236
- Pathology and Forensic Medicine 160
- Rheumatology 155
Countries citing papers authored by Reigetsu Yoshikawa
This map shows the geographic impact of Reigetsu Yoshikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reigetsu Yoshikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reigetsu Yoshikawa more than expected).
Fields of papers citing papers by Reigetsu Yoshikawa
This network shows the impact of papers produced by Reigetsu Yoshikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reigetsu Yoshikawa. The network helps show where Reigetsu Yoshikawa may publish in the future.
Co-authorship network of co-authors of Reigetsu Yoshikawa
This figure shows the co-authorship network connecting the top 25 collaborators of Reigetsu Yoshikawa. A scholar is included among the top collaborators of Reigetsu Yoshikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reigetsu Yoshikawa. Reigetsu Yoshikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 20 | |
| 3 | 2 | |
| 4 | 6 | |
| 5 | 10 | |
| 6 | 6 | |
| 7 | 17 | |
| 8 | 11 | |
| 9 | 13 | |
| 10 | 30 | |
| 11 | 62 | |
| 12 | 11 | |
| 13 | 44 | |
| 14 | Polysaccharide-K (PSK) inhibits distant metastasis in colorectal cancer dependent on ECA39 | 1 |
| 15 | 6 | |
| 16 | 139 | |
| 17 | 1 | |
| 18 | Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. | 169 |
| 19 | 33 | |
| 20 | 3 |
About Reigetsu Yoshikawa
Reigetsu Yoshikawa is a scholar working on Hepatology, Oncology and Gastroenterology, having authored 36 papers that have together received 711 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Gastric Cancer Management and Outcomes (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). The work is most often cited by research in Oncology (292 citations), Rheumatology (155 citations) and Hepatology (74 citations). Reigetsu Yoshikawa has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Hidenori Yanagi, Tomoko Hashimoto-Tamaoki, Masafumi Noda, Yoshinori Fujiwara, Tomohiko Yamamura, M. Kusunoki, Jun-ichi Furuyama, Takehira Yamamura, Joji Utsunomiya and Tohru Tsujimura. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.